214 related articles for article (PubMed ID: 24703886)
1. An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome.
Al-Al-Shaikh M; Michel F; Parratte B; Kastler B; Vidal C; Aubry S
Diagn Interv Imaging; 2015 Jan; 96(1):37-43. PubMed ID: 24703886
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Botulinum Toxin, Local Anesthetics, and Corticosteroids in Patients With Piriformis Syndrome: A Systematic Review and Meta-analysis.
Hilal FM; Bashawyah A; Allam AE; Lam KHS; El Oumri AA; Galluccio F; AlKharabsheh A; Kaye AD; Salti A; Varrassi G
Pain Physician; 2022 Aug; 25(5):325-337. PubMed ID: 35901473
[TBL] [Abstract][Full Text] [Related]
3. MRI verification of ultrasound-guided infiltrations of local anesthetics into the piriformis muscle.
Blunk JA; Nowotny M; Scharf J; Benrath J
Pain Med; 2013 Oct; 14(10):1593-9. PubMed ID: 23758696
[TBL] [Abstract][Full Text] [Related]
4. Computer-tomographic verification of ultrasound-guided piriformis muscle injection: a feasibility study.
Fabregat G; Roselló M; Asensio-Samper JM; Villaneuva-Pérez VL; Martínez-Sanjuan V; De Andrés J; Eichenberger U
Pain Physician; 2014; 17(6):507-13. PubMed ID: 25415775
[TBL] [Abstract][Full Text] [Related]
5. Piriformis syndrome: long-term follow-up in patients treated with percutaneous injection of anesthetic and corticosteroid under CT guidance.
Masala S; Crusco S; Meschini A; Taglieri A; Calabria E; Simonetti G
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):375-82. PubMed ID: 21607823
[TBL] [Abstract][Full Text] [Related]
6. Piriformis syndrome: pain response outcomes following CT-guided injection and incremental value of botulinum toxin injection.
Yan K; Xi Y; Hlis R; Chhabra A
Diagn Interv Radiol; 2021 Jan; 27(1):126-133. PubMed ID: 33252337
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for botulinum neurotoxin injections in piriformis syndrome.
Yi KH; Lee KL; Lee JH; Hu HW; Lee K; Seo KK; Kim HJ
Clin Anat; 2021 Oct; 34(7):1028-1034. PubMed ID: 33347678
[TBL] [Abstract][Full Text] [Related]
8. CT-guided piriformis muscle injection for the treatment of piriformis syndrome.
Ozisik PA; Toru M; Denk CC; Taskiran OO; Gundogmus B
Turk Neurosurg; 2014; 24(4):471-7. PubMed ID: 25050669
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection strategy of intractable and relapsed piriformis syndrome: A case report.
Kwon SY; Jun EH; Park SJ; Kim Y
Medicine (Baltimore); 2022 Oct; 101(42):e30950. PubMed ID: 36281083
[TBL] [Abstract][Full Text] [Related]
10. Brief review: piriformis syndrome: etiology, diagnosis, and management.
Jankovic D; Peng P; van Zundert A
Can J Anaesth; 2013 Oct; 60(10):1003-12. PubMed ID: 23893704
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature.
Santamato A; Micello MF; Valeno G; Beatrice R; Cinone N; Baricich A; Picelli A; Panza F; Logroscino G; Fiore P; Ranieri M
Toxins (Basel); 2015 Aug; 7(8):3045-56. PubMed ID: 26266421
[TBL] [Abstract][Full Text] [Related]
12. Case report and review of the potential role of the Type A piriformis muscle in dynamic sciatic nerve entrapment variant of piriformis syndrome.
Koh E; Webster D; Boyle J
Surg Radiol Anat; 2020 Oct; 42(10):1237-1242. PubMed ID: 32112284
[TBL] [Abstract][Full Text] [Related]
13. Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a double-blinded, randomized controlled study.
Misirlioglu TO; Akgun K; Palamar D; Erden MG; Erbilir T
Pain Physician; 2015; 18(2):163-71. PubMed ID: 25794202
[TBL] [Abstract][Full Text] [Related]
14. [The piriformis syndrome-a special indication for botulinum toxin].
Hermann W
Nervenarzt; 2020 Feb; 91(2):99-106. PubMed ID: 32020236
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of piriformis syndrome: a magnetic resonance imaging-based comparison study].
Huang ZF; Yang DS; Shi ZJ; Xiao J
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):42-45. PubMed ID: 29343028
[No Abstract] [Full Text] [Related]
16. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study.
Fishman LM; Konnoth C; Rozner B
Am J Phys Med Rehabil; 2004 Jan; 83(1):42-50; quiz 51-3. PubMed ID: 14709974
[TBL] [Abstract][Full Text] [Related]
17. Piriformis muscle syndrome: diagnostic criteria and treatment of a monocentric series of 250 patients.
Michel F; Decavel P; Toussirot E; Tatu L; Aleton E; Monnier G; Garbuio P; Parratte B
Ann Phys Rehabil Med; 2013 Jul; 56(5):371-83. PubMed ID: 23684470
[TBL] [Abstract][Full Text] [Related]
18. Effect of Mannitol plus Vitamins B in the management of patients with piriformis syndrome.
Huang ZF; Lin BQ; Torsha TT; Dilshad S; Yang DS; Xiao J
J Back Musculoskelet Rehabil; 2019; 32(2):329-337. PubMed ID: 30412481
[TBL] [Abstract][Full Text] [Related]
19. Accessory piriformis muscle: an easily identifiable cause of piriformis syndrome on magnetic resonance imaging.
Sen A; Rajesh S
Neurol India; 2011; 59(5):769-71. PubMed ID: 22019672
[No Abstract] [Full Text] [Related]
20. Piriformis syndrome: muscle thickness or volume does not correlate with response to CT-guided injection.
Hlis R; Yan K; Xi Y; Chhabra A
Skeletal Radiol; 2022 Jul; 51(7):1407-1414. PubMed ID: 34921609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
